Efficacy and Tolerability Study of Natura-Alpha in the Treatment of Patients With Active Ulcerative Colitis.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 02 Nov 2011
At a glance
- Drugs TAK 114 (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 02 Nov 2011 Results presented at the 76th Annual Scientific Meeting of the American College of Gastroenterology.
- 24 Jun 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History